Overview
Emmanouil Nikolousis practices in Birmingham, United Kingdom. Nikolousis is rated as an Advanced expert by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Their top areas of expertise are Acute Monoblastic Leukemia (AmoL), Graft Versus Host Disease (GvHD), Hepatic Venoocclusive Disease with Immunodeficiency, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
Their clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Acute Monoblastic Leukemia (AmoL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Monoblastic Leukemia (AmoL)Nikolousis isAdvanced. Learn about Acute Monoblastic Leukemia (AmoL).
- Bone Marrow TransplantNikolousis isAdvanced. Learn about Bone Marrow Transplant.
- Experienced
- Acute Myeloid Leukemia (AML)Nikolousis isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Autoimmune Hemolytic AnemiaNikolousis isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Graft Versus Host Disease (GvHD)Nikolousis isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Hepatic Venoocclusive Disease with Immunodeficiency
- LeukemiaNikolousis isExperienced. Learn about Leukemia.
- Multiple MyelomaNikolousis isExperienced. Learn about Multiple Myeloma.